Clinical Trials Logo

Suicide clinical trials

View clinical trials related to Suicide.

Filter by:

NCT ID: NCT06225661 Recruiting - Suicide Clinical Trials

Focused Suicide Prevention Strategy for Youth Presenting to the Emergency Department With Suicide Related Behaviour

IAMSAFE
Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Suicide is the leading cause of death due to illness among Canadian youth, claiming more lives than any medical illness, including cancer. Suicide prevention is possible, and early intervention is needed. The investigators will examine the effectiveness of a previously-piloted, ED-based suicide prevention intervention, across Canadian sites, using a randomized clinical trial design. The investigators will determine whether the patient- and family-centered intervention is more effective than enhanced usual care in reducing suicide-related behaviors in 330 youth at high-risk of suicide.

NCT ID: NCT06223867 Recruiting - Suicidal Ideation Clinical Trials

Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A

Jaspr-PartA
Start date: February 23, 2024
Phase: N/A
Study type: Interventional

This Study will comprehensively evaluate a multi-component suicide prevention technology (Jaspr Health) that facilitates delivery of suicided-related evidence-based practices (EBPs) while replacing wasted waiting time with productive time in the Emergency Departments (EDs). The EBPs satisfy several key performance elements for systems adopting Zero Suicide. A Complementary Randomized Controlled Trial and Real-World Study for Efficacy, Effectiveness, and Implementation Study Design (CREID) will be used

NCT ID: NCT06216327 Recruiting - Suicide Clinical Trials

Safety Planning 6+

SP6+
Start date: January 8, 2024
Phase: N/A
Study type: Interventional

Access to lethal methods of self-harm such as firearms and medications increases risk for suicide. As such, VA/DoD guidelines for the care of individuals with elevated suicide risk include recommendations that clinicians deliver interventions to reduce access to lethal methods of suicide among patients who are identified as having elevated suicide risk. However, no interventions have been developed or tested among Veterans seeking emergency care - a population previously identified as having elevated risk. The aim of this study is to pilot test a lethal means safety intervention developed specifically for Veterans who seek care in VHA emergency departments and urgent care settings and are identified as having elevated suicide risk.

NCT ID: NCT06210100 Recruiting - Suicidal Ideation Clinical Trials

aiTBS for NSSI and Suicide in Adolescent Depression

Start date: January 18, 2024
Phase: N/A
Study type: Interventional

Repetitive transcranial magnetic stimulation (rTMS) has been successfully used to help patients with treatment resistant depression. However, its role in alleviating self injuries with and without suicidal ideation remained uncertain. This trial will compare the effectiveness of active accelerated intermittent theta burst stimulation (aiTBS) rTMS to a placebo control on non-suicidal self injury (NSSI) and suicidal attempts in patients with major depressive disorder.

NCT ID: NCT06208293 Recruiting - Suicide Clinical Trials

Suicide Prevention Integration Into Task-shifted Mental Health Interventions

KPZ
Start date: May 13, 2024
Phase: N/A
Study type: Interventional

Investigators will conduct a pilot clinical trial to assess the feasibility and acceptability of implementing a Suicide Prevention Package (SuPP) within an existing task-shifted depression intervention in rural Pakistan. This pilot research lays the groundwork for a future project to scale a package for multi-level suicide prevention strategies that can be integrated into community based mental health programs, particularly targeting individuals living in low-resourced settings. As the model is designed to be easily adapted and integrated, investigators anticipate the findings will be valuable for all researchers looking to improve population health and mental health services in disadvantaged settings.

NCT ID: NCT06203899 Recruiting - Depressive Symptoms Clinical Trials

Depression and Suicide Prevention in Adolescents Attending Special Schools

STORM
Start date: December 13, 2023
Phase: N/A
Study type: Interventional

Depression is a major public health concern. In Dutch adolescents, the prevalence of major depressive disorder is estimated at 3.8%, and one in five adolescents report depressive symptoms. Depression is a risk factor in adolescent suicide. School-based prevention programs, for example the STORM approach, are effective in decreasing depressive symptoms among adolescents with elevated depressive symptoms at screening. However, not all adolescents attend general education. In the Netherlands, 7% of all adolescents enters special education (voortgezet speciaal onderwijs and prakijkonderwijs). They form a vulnerable subgroup concerning developing depressive symptoms and suicidality. To adapt and implement programs for these students, is complex yet crucial. This study aims to screen adolescents, offer them a prevention program to prevent the onset or continuation of depression and evaluate the effectiveness of this program. It is a randomised controlled trial with two conditions. The main study parameter is depressive symptomatology. Secondary study parameters are suicidality, anxiety and somatic complaints. Eligible students enter the second or third grade of special education, presenting elevated depressive symptoms. All adolescents will be screened for depressive and suicidal symptoms. Those reporting suicidality will be guided to specialised care, together with their parents. Adolescents with elevated depressive symptoms in the experimental condition will be offered the CBT-based preventive group training Op Volle Kracht in their school setting. The control condition consists of monitoring, and is offered the training if the intervention has shown to be effective. Participants will fill in longitudinal measurements. At all times, adolescents will be guided to mental health care if necessary. Furthermore, teachers in all participating schools will attend a training on how to detect and address depressive and suicidal symptoms among adolescents. The potential value of the study is that we can offer adolescents in the special educational sector a prevention program that is proven to be effective. In order to achieve this goal we need to evaluate the effectiveness of this prevention program in this target group. We are of opinion, however, that the risks associated with participation can be considered negligible. It is specifically aimed at depressive symptoms, within a population which receives care for other problems.

NCT ID: NCT06191484 Recruiting - Suicide Clinical Trials

Risk and Resilience to Suicide Following Late-Life Spousal Bereavement

RISE
Start date: November 20, 2023
Phase: N/A
Study type: Interventional

The purpose of the RISE study is to examine how the 24-hour rhythm of sleep and social activity relate to mood and suicidal ideation among older adults that recently lost a spouse or life partner.

NCT ID: NCT06191289 Recruiting - Suicide Clinical Trials

Neurocognitive Mechanisms of Perimenstrual Estrogen Effects on Suicidality

CLEAR-4
Start date: March 16, 2024
Phase: Phase 2
Study type: Interventional

This within-person, crossover, 2-condition, placebo-controlled study compares the impact of two perimenstrual conditions on severity of suicidal symptoms in females with past-month suicidality but minimal risk of imminent suicide attempt. The two conditions are (1) perimenstrual administration of estradiol and (2) natural perimenstrual withdrawal from estradiol during placebo.

NCT ID: NCT06164106 Recruiting - Suicide Prevention Clinical Trials

Feasibility Trial of a Single Session of Crisis Response Planning for Youth at High Risk for Suicide

Start date: November 1, 2023
Phase: N/A
Study type: Interventional

The current study is a clinical trial, meaning a research study in which human subjects are prospectively assigned to one or more interventions to evaluate the effects of those interventions on health-related behavioral outcomes. Specifically, male and female adolescents with current suicidal intent will be randomly assigned to receive either a 1-hour session of virtual crisis response planning (CRP), a 1-hour session of in-person CRP, or a 1-hour session of standard crisis risk management (treatment as usual). The feasibility and acceptability of the virtual CRP, compared to in-person CRP, will be assessed 14 days post-treatment. Additional assessments of changes in mood, behavior, and suicidality will be collected daily for 14 days post-treatment via ecological momentary assessments. The investigators hypothesize the following: 1) Virtual CRP will be rated as more feasible and acceptable compared to traditional CRP and treatment as usual interventions; 2) Both versions of CRP will be associated with changes in frequency and severity of suicidal ideation and behavior compared to treatment as usual; 3) Virtual CRP will be equally as effective as traditional CRP at reducing suicide risk, suggesting that virtual CRP is a promising scalable intervention adaptation.

NCT ID: NCT06163612 Recruiting - Clinical trials for Major Depressive Disorder

Effect of Suicidality on Social Cognition

Start date: September 1, 2022
Phase:
Study type: Observational

Major Depressive Disorder (MDD) is a very common illness that is usually treated with antidepressant medication. Depression can be caused by many things such as childhood experiences, genetics, and changes in the way the body and brain function. It is most likely caused by a combination of several of these factors. The prevalence of suicide attempt in Major Depressive Disorder (MDD) is about 20%. Risk for suicide attempt can be increased by many things such as negative life events, genetics, and changes in the way the body and brain function. It is most likely caused by a combination of several of these factors. In this study, the investigators will be collecting detailed information about participants' psychiatric history and depression symptoms, as well as brain scans. The goal is to use this information to help us determine what predicts suicide attempt history.